Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Parkinson’s protein blueprint could help fast-track new treatments

Written by | 11 Jan 2022

Researchers have solved a decade-long mystery about a critical protein linked to Parkinson’s disease that could help to fast-track treatments for the incurable disease. The research, published in Nature,… read more.

Memory T cells from previous common cold infections protect against infection with SARS-CoV-2

Written by | 11 Jan 2022

A new study, published in Nature Communications confirms what many people have suspected for a long time – namely that previous human coronavirus infection e.g. with the common cold, could… read more.

Are hedgehogs to blame for superbugs?

Written by | 10 Jan 2022

The threat of antimicrobial resistance (AMR), whereby antibiotics not longer work well on bacterial illness, is a slow-burning pandemic with the potential to eclipse even the worst of… read more.

School closures improved sleep for teenagers

Written by | 10 Jan 2022

The closure of schools in spring 2020 had a negative effect on the health and well-being of many young people. But home-schooling also had a positive flipside for… read more.

Could umbilical cord stem cells cure blood cancer?

Written by | 9 Jan 2022

Stem cells have promised to be the catalyst for major strides in medical research for decades. While progress in some fields has been slower than initially hoped, scientists… read more.

Don’t bet on lottery to boost vaccine uptake

Written by | 9 Jan 2022

Most people offered a COVID-19 vaccine in 2021 kept their appointment and rolled up their sleeves. However, as the year wore on, some countries struggled with vaccine hesitancy…. read more.

FDA approves Dupixent as add-on treatment for moderate-to-severe asthma – Sanofi + Regeneron

Written by | 8 Jan 2022

The FDA has approved Dupixent (dupilumab), from Sanofi + Regeneron, as an add-on maintenance treatment of patients aged 6 to 11 years with moderate-to-severe asthma characterized by an… read more.

Sloan Kettering Institute scientists design CAR T cells to activate cancer pro-drugs at the disease site

Written by | 8 Jan 2022

Immunotherapies called chimeric antigen receptor (CAR) T cells use genetically engineered versions of a patient’s own immune cells to fight cancer. These treatments have energized cancer care, especially for people… read more.

What pharmacists need to know about cannabidiol

Written by | 8 Jan 2022

Community pharmacists can be an important source of information about cannabidiol (CBD) but they also need to ensure that the CBD products that they sell are correctly licensed… read more.

FDA application for first dispersible single tablet regimen containing dolutegravir (DTG) for children living with HIV – ViiV HealthCare

Written by | 7 Jan 2022

ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, has announced it has made a regulatory submission to the… read more.

Cancer deaths rose to 10 million worldwide in 2019

Written by | 7 Jan 2022

Recent trends also highlight global disparities in cancer burden. Cancer deaths rose to 10 million and new cases jumped to over 23 million globally in 2019, according to… read more.

Dosing and administration of cannabidiol

Written by | 7 Jan 2022

Natural cannabidiol distillate is superior to synthetic CBD because of the benefits of the ‘entourage effect’, according to Moyra Cosgrove, Head of Nutrition for Naturecan, a company that… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.